Sales of products for the production animal category in emerging markets were up significantly for French drugmaker Virbac in the first half. It was helped in South America by the integration of ...

Virbac consolidated revenue in the fourth quarter reached 225.7 M€, a significant +9.2% growth compared to the same period of last year and a +8.6% increase at constant scope. Growth was driven ...

This is getting old. I’m tired of recall notices. At least this recall won’t hurt your dog. Virbac Animal Health has recalled two lots of Iverhart Plus flavored chewable heartworm tablets. The lot ...